Mandate

Vinge Advises Carlsberg in Offer for Scottish & Newcastle

January 30, 2008

On January the 25th 2008 the Board of Directors of Carlsberg A/S and Heineken N.V, as one part, and, as the other part, Scottish & Newcastle plc, announced that they had agreed upon the terms in the offer for Scottish & Newcastle which in turn sprang from a jointly owned company by Carlsberg and Heineken. The offer is based upon Scottish & Newcastle estimated value of GBP 7,6 billion. Baltic Beverages Holding AB, the jointly owned company of Carlsberg and Scottish & Newcastle, has played an important role in the connection to the discussions that have preceded the agreement. Vinge acts as legal advisors to Carlsberg on Swedish queries.

Vinge’s team included Hans Bagger and Finn Madsen (Litigation), Erik Sjöman (Corporate Law and Public M&A), assisted by, among others, Christina Ramberg and Andreas Eriksson.       

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026